- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06545786
Intraoperative Diagnosis of Neurocognitive Complications Via Electroencephalographic Analysis
Intraoperative Diagnosis of Neurocognitive Complications Via Electroencephalographic (IDEA Network)
Postoperative neurocognitive disorders (PND) are serious and common complications after surgery, especially in elderly patients. These disorders can affect cognitive functions for years, deteriorating quality of life and increasing hospital stays and medical costs. Diagnosing PND is challenging due to their varied manifestations, such as memory and attention problems, and the lack of standardized criteria and biomarkers.
One well-studied form of PND is postoperative delirium (POD). According to the ICD-10, POD is an organic cerebral syndrome characterized by disturbances in consciousness, attention, perception, and other cognitive functions. Researchers suggest that POD development involves a combination of predisposing and precipitating factors.
Electroencephalography (EEG) has been used in anesthesiology to assess anesthesia depth and intraoperative awareness. Modern EEG analysis methods, like spectral analysis, offer new ways to evaluate patients' neurophysiological states. Studies show that EEG monitoring can predict complications such as intraoperative stroke and delirium, particularly in cardiothoracic and neurosurgical operations.
The relationship between EEG patterns and POD is not well understood. Specific EEG patterns may indicate the risk of POD, aiding in the identification of risk factors and prevention methods. This could help anesthesiologists and surgeons optimize their approaches, reducing the risk of cognitive complications.
Study Overview
Status
Intervention / Treatment
Detailed Description
Postoperative Neurocognitive Disorders (PND) are one of the most serious and common complications following surgery, especially in elderly patients. Postoperative neurocognitive disorders can impact cognitive functions for a prolonged period post-surgery, sometimes lasting several years. This not only deteriorates the quality of life but also increases hospitalization time and medical costs.
The difficulty in diagnosing postoperative neurocognitive disorders is that postoperative neurocognitive disorders can manifest in various forms, including memory, attention, and executive function problems. The lack of standardized diagnostic criteria and clear biomarkers complicates early identification and prognosis of postoperative neurocognitive disorders.
One of the most studied forms of postoperative neurocognitive disorders is postoperative delirium (POD). Currently, the concept of postoperative delirium development suggests a combination of predisposing and precipitating factors. Furthermore, according to the ICD-10, postoperative delirium is defined as an etiologically nonspecific organic cerebral syndrome characterized by disturbances in consciousness, attention, perception, thinking, memory, psychomotor behavior, emotions, and the sleep-wake cycle. The indication of an organic nature of the lesion prompts researchers to explore the possibility of diagnosing brain dysfunctions clinically manifesting as postoperative delirium.
Electroencephalography (EEG) has long been used in anesthesiology to assess the depth of anesthesia and the risk of awareness during surgery. With the use of modern analysis algorithms, such as spectral analysis and synchronization between different brain regions, electroencephalography opens new horizons for assessing the patient's neurophysiological state. Currently, the use of electroencephalography for monitoring cerebral perfusion and oxygenation is being studied, which is especially critical during cardiothoracic and neurosurgical operations. One study showed that a new interhemispheric similarity index in electroencephalography could serve as an indicator of the risk of complications such as intraoperative stroke and delirium after cardiac surgery. These data demonstrate the possibility of using electroencephalography monitoring as a tool for predicting adverse neurocognitive outcomes.
The relationship between electroencephalography and postoperative delirium has not been sufficiently studied. The hypothesis is that specific electroencephalography patterns may serve as indicators of the organic substrate development of postoperative delirium, which may lead to the study of risk factors and methods of their prevention. This, in turn, will allow anesthesiologists and surgeons to optimize approaches to anesthesia and surgical intervention, minimizing the risk of negative cognitive consequences.
Study Type
Enrollment (Estimated)
Contacts and Locations
Study Contact
- Name: Valery Likhvantsev, PhD
- Phone Number: 89036235982
- Email: lik0704@gmail.com
Study Contact Backup
- Name: Levan Berikashvili, PhD
- Phone Number: 89263308968
- Email: levan.berikashvili@mail.ru
Study Locations
-
-
Moscow region
-
Moscow, Moscow region, Russian Federation, 115446
- Recruiting
- City clinical hospital named after SS Yudin
-
Contact:
- Valery Likhvantsev, PhD
- Phone Number: 89036235982
- Email: lik0704@gmail.com
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Sampling Method
Study Population
Description
Inclusion Criteria:
- Age ≥ 18 years
- Scheduled non-cardiac surgery of intermediate or high risk
- General anesthesia using inhalational anesthetics
- Informed consent from the patient to participate in the study
Exclusion Criteria:
- Preoperative MMSE score less than 20 points
- History of any mental illness
- Use of psychotropic drugs within 1 month prior to inclusion in the study
- Presence of neuromuscular diseases
- Neurosurgical procedures
- Inability to undergo preoperative testing for any reason
Study Plan
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
|---|---|
|
Non-cardiac surgery
Patients scheduled for non-cardiac surgery of intermediate to high risk
|
EEG recording will be performed using the standard 16-electrode configuration according to the international "10-20" system.
During the recording, electrode impedances will be maintained at a level not exceeding 5 kilo-ohms.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Prognostic value of mean intraoperative alpha rhythm power for the development of postoperative delirium
Time Frame: Through study completion, an average of 3 year
|
The prognostic value assessment is performed using the area under the ROC curve (AUROC).
The value ranges from 0.5 to 1.0.
The closer the AUROC value is to one, the higher the prognostic capability of the electroencephalography.
|
Through study completion, an average of 3 year
|
|
Prognostic value of mean intraoperative alpha rhythm power for the development of early postoperative neurocognitive disorders
Time Frame: Through study completion, an average of 3 year
|
The prognostic value assessment is performed using the area under the ROC curve (AUROC).
The value ranges from 0.5 to 1.0.
The closer the AUROC value is to one, the higher the prognostic capability of the electroencephalography.
|
Through study completion, an average of 3 year
|
|
Prognostic value of mean intraoperative alpha rhythm power for the development of intraoperative silent brain infarction
Time Frame: Through study completion, an average of 3 year
|
The prognostic value assessment is performed using the area under the ROC curve (AUROC).
The value ranges from 0.5 to 1.0.
The closer the AUROC value is to one, the higher the prognostic capability of the electroencephalography.
|
Through study completion, an average of 3 year
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
28-days mortality
Time Frame: 28 days
|
Number of deaths in period of 28 days after enrollment
|
28 days
|
|
Prognostic value of maximum intraoperative alpha rhythm power for the development of postoperative delirium
Time Frame: Through study completion, an average of 3 year
|
The prognostic value assessment is performed using the area under the ROC curve (AUROC).
The value ranges from 0.5 to 1.0.
The closer the AUROC value is to one, the higher the prognostic capability of the electroencephalography.
|
Through study completion, an average of 3 year
|
|
Prognostic value of maximum intraoperative alpha rhythm power for the development of early postoperative neurocognitive disorders
Time Frame: Through study completion, an average of 3 year
|
The prognostic value assessment is performed using the area under the ROC curve (AUROC).
The value ranges from 0.5 to 1.0.
The closer the AUROC value is to one, the higher the prognostic capability of the electroencephalography.
|
Through study completion, an average of 3 year
|
|
Prognostic value of maximum intraoperative alpha rhythm power for the development of silent brain infarction
Time Frame: Through study completion, an average of 3 year
|
The prognostic value assessment is performed using the area under the ROC curve (AUROC).
The value ranges from 0.5 to 1.0.
The closer the AUROC value is to one, the higher the prognostic capability of the electroencephalography.
|
Through study completion, an average of 3 year
|
|
The prognostic capability of the "burst suppression" pattern for predicting the development of silent brain infarction
Time Frame: Through study completion, an average of 3 year
|
The prognostic value assessment is performed using the area under the ROC curve (AUROC).
The value ranges from 0.5 to 1.0.
The closer the AUROC value is to one, the higher the prognostic capability of the electroencephalography.
|
Through study completion, an average of 3 year
|
|
The prognostic capability of the "burst suppression" pattern for predicting the development of postoperative delirium.
Time Frame: Through study completion, an average of 3 year
|
The prognostic value assessment is performed using the area under the ROC curve (AUROC).
The value ranges from 0.5 to 1.0.
The closer the AUROC value is to one, the higher the prognostic capability of the electroencephalography.
|
Through study completion, an average of 3 year
|
|
The prognostic capability of the "burst suppression" pattern for predicting the development of early postoperative neurocognitive disorders.
Time Frame: Through study completion, an average of 3 year
|
The prognostic value assessment is performed using the area under the ROC curve (AUROC).
The value ranges from 0.5 to 1.0.
The closer the AUROC value is to one, the higher the prognostic capability of the electroencephalography.
|
Through study completion, an average of 3 year
|
|
The prognostic value of early postoperative neurocognitive disorders for predicting the development of postoperative delirium.
Time Frame: Through study completion, an average of 3 year
|
The prognostic value assessment is performed using the area under the ROC curve (AUROC).
The value ranges from 0.5 to 1.0.
The closer the AUROC value is to one, the higher the prognostic capability of the electroencephalography.
|
Through study completion, an average of 3 year
|
|
The prognostic value of postoperative delirium for predicting the development of silent brain infarction
Time Frame: Through study completion, an average of 3 year
|
The prognostic value assessment is performed using the area under the ROC curve (AUROC).
The value ranges from 0.5 to 1.0.
The closer the AUROC value is to one, the higher the prognostic capability of the electroencephalography.
|
Through study completion, an average of 3 year
|
|
1-year mortality
Time Frame: 1 year
|
Number of deaths in period of 1 year after enrollment
|
1 year
|
Other Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Serum level of S100 beta protein
Time Frame: within 1 hour before surgery, 1 hour after surgery
|
within 1 hour before surgery, 1 hour after surgery
|
|
Serum level of Interleukin-6
Time Frame: within 1 hour before surgery, 1 hour after surgery
|
within 1 hour before surgery, 1 hour after surgery
|
Collaborators and Investigators
Investigators
- Principal Investigator: Valery Likhvantsev, PhD, Federal Research and Clinical Centre of Intensive Care Medicine and Rehabilitology
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- IDEA Network
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
product manufactured in and exported from the U.S.
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Postoperative Delirium
-
Wonkwang University HospitalCompleted
-
Sengkang General HospitalRecruitingDelirium and Post-operative Cognitive Dysfunction (POCD) | Delirium, Postoperative | Delirium - PostoperativeSingapore
-
Chinese PLA General HospitalXiangya Hospital of Central South University; The Affiliated Nanjing Drum Tower... and other collaboratorsCompletedPostoperative Delirium (POD)China
-
Nanjing First Hospital, Nanjing Medical UniversityActive, not recruitingPostoperative Delirium (POD)China
-
Qin ZhangNational Natural Science Foundation of ChinaRecruiting
-
Qin ZhangNational Natural Science Foundation of ChinaRecruitingDelirium, PostoperativeChina
-
Hao LiCompleted
-
University Hospital, Basel, SwitzerlandInnosuisse - Swiss Innovation AgencyCompletedPostoperative Delirium (POD)Switzerland
-
Konya City HospitalCompletedPREOPERATIVE SLEEP QUALITY ON POSTOPERATIVE DELIRIUMTurkey
-
Riverside University Health System Medical CenterNot yet recruitingPostoperative Delirium (POD) | Norepinephrine | Ephedrine
Clinical Trials on Intraoperative electroencephalography
-
University of OxfordOxford University Hospitals NHS TrustActive, not recruitingDelirium | Cognitive Impairment | Postoperative Cognitive Dysfunction | Cognitive DeclineUnited Kingdom
-
Centre Hospitalier Universitaire de BesanconTerminated
-
Daegu Catholic University Medical CenterCompletedAttention Deficit Hyperactivity Disorder | Psychiatric Diagnosis | Diagnosis, PsychiatricKorea, Republic of
-
Rennes University HospitalCompleted
-
University Hospital, CaenCentre Hospitalier Universitaire de BesanconNot yet recruitingNeurodevelopmental Changes (Childhood, Ageing)
-
Assistance Publique Hopitaux De MarseilleRecruiting
-
Parc de Salut MarAelis Farma; StarlabRecruiting
-
Ulrich MehnertNCCR (National Center of Competence in Resaerch, Switzerland)CompletedHealthy | Neurogenic Bladder Dysfunction Nos | Nonneurogenic Neurogenic Bladder DysfunctionSwitzerland
-
Guangzhou Women and Children's Medical CenterBeijing X-Magtech Technology LimitedRecruitingRefractory Epilepsy in ChildrenChina
-
Central Hospital, Nancy, FranceInstitut National de la Santé Et de la Recherche Médicale, France; CHU de Reims and other collaboratorsCompletedPartial EpilepsyFrance